Condition
Chronic Graft vs. Host Disease clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Chronic Graft vs. Host Disease clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 4 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
Ruxolitinib for corticosteroid-refractory chronic graft-versus-host disease in Chinese patients
This trial will try ruxolitinib in Chinese adolescents (12+) and adults whose chronic graft-versus-host disease has not improved with corticosteroids.
-
Understanding chronic graft-versus-host disease outcomes
This study is trying to understand how different factors affect the outcomes for patients with chronic graft-versus-host disease after a stem cell transplant, to help improve their treatment.
Related topics
Quick answers
How many Chronic Graft vs. Host Disease clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 4: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.